Skip to main content
logo
Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,260.00
+145.00 (6.86%)
At close: Jul 27, 2026

Kangstem Biotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
183,312218,206113,229133,971109,830124,057
Market Cap Growth
134.09%92.71%-15.48%21.98%-11.47%-36.85%
Enterprise Value
160,108199,99595,018129,76185,183115,828
Last Close Price
1949.002320.001689.512003.152103.332375.78

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
53.5561.0814.6210.556.7410.00
PB Ratio
2.943.162.622.672.081.74
P/TBV Ratio
4.024.182.682.822.271.85

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
46.7755.9812.2710.215.239.34

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.150.140.200.270.250.20
Net Debt / Equity Ratio
-0.37-0.42-0.23-0.47-0.44-0.60
Net Debt / EBITDA Ratio
1.521.910.851.261.402.26
Net Debt / FCF Ratio
1.512.360.501.331.191.97
Asset Turnover
-0.050.110.160.180.13
Inventory Turnover
-3.264.7621.1618.5717.37
Quick Ratio
4.124.752.922.072.733.38
Current Ratio
4.565.253.692.553.223.80
Return on Equity (ROE)
-19.21%-18.65%-15.18%-45.17%-32.55%-36.40%
Return on Assets (ROA)
--16.06%-13.52%-17.59%-13.99%-15.31%
Return on Capital Employed (ROCE)
-26.40%-24.10%-30.80%-36.40%-31.00%-26.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.53%-4.80%-6.77%-16.38%-18.43%-17.21%
FCF Yield
-8.40%-5.65%-17.29%-13.35%-17.82%-17.43%
Buyback Yield / Dilution
-59.08%-23.21%-38.90%-7.02%-36.23%-24.89%